SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001787306-24-000131
Filing Date
2024-09-05
Accepted
2024-09-05 17:56:27
Documents
1
Period of Report
2024-09-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1725573381.html 4  
1 FORM 4 wk-form4_1725573381.xml 4 4077
  Complete submission text file 0001787306-24-000131.txt   5689
Mailing Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Issuer) CIK: 0001787306 (see all company filings)

IRS No.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ARCUTIS BIOTHERAPEUTICS, INC. 2945 TOWNSGATE ROAD, SUITE 110 WESTLAKE VILLAGE CA 91361
Business Address
Welgus Howard G. (Reporting) CIK: 0001801050 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39186 | Film No.: 241282400